News tagged with ciprofloxacin
Related topics: antibiotics
Ciprofloxacin (INN) is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. It is a second-generation fluoroquinolone antibacterial. It kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops synthesis of DNA and of protein.
Ciprofloxacin was first patented in 1983 by Bayer A.G. and subsequently approved by the U.S. Food and Drug Administration (FDA) in 1987. Ciprofloxacin has 12 FDA-approved human uses and other veterinary uses, but it is often used for unapproved uses (off-label). Ciprofloxacin interacts with other drugs, herbal and natural supplements, and thyroid medications.
As of 2011 the FDA has added two black box warnings for this drug in reference to spontaneous tendon ruptures and the fact that ciprofloxacin may cause worsening of myasthenia gravis symptoms, including muscle weakness and breathing problems. Such an adverse reaction is a potentially life-threatening event and may require ventilatory support.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
(HealthDay)—The relative proportion of methicillin-resistant Staphylococcus aureus (MRSA) is increasing in S. aureus isolates, and methicillin-sensitive S. aureus (MSSA) is becoming increasingly resista ...
Diseases, Conditions, Syndromes Apr 18, 2013 | 5 / 5 (1) | 0
(HealthDay)—Klebsiella pneumoniae (K. pneumoniae) isolates from U.S. inpatients are becoming increasingly resistant to antimicrobial agents, according to a study published in the January issue of Emerging I ...
Diseases, Conditions, Syndromes Dec 20, 2012 | not rated yet | 0
The use of a commonly prescribed antibiotic is a major contributor to the spread of infection in hospitals by the 'superbug' MRSA, according to new research. The study also found that increasing measures to prevent infection ...
Diseases, Conditions, Syndromes Sep 21, 2012 | not rated yet | 0
Bacteria that cause the main food-borne infections among people in the European Union commonly show resistance to widely-used antibiotics and antimicrobials, an EU report showed Wednesday.
Diseases, Conditions, Syndromes Mar 14, 2012 | 5 / 5 (1) | 0
Short-term use of the antibiotic cefpodoxime for the treatment of women with uncomplicated cystitis (bladder infection) did not meet criteria for noninferiority for achieving clinical cure compared with ciprofloxacin, a drug ...
Diseases, Conditions, Syndromes Feb 07, 2012 | not rated yet | 0
In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten ...
Diseases, Conditions, Syndromes Nov 29, 2011 | not rated yet | 0
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists ...
Cancer Nov 23, 2011 | 4.8 / 5 (6) | 3 |
The introduction of new antibiotic regimes to tackle hospital-acquired infections, such as C. difficile, must take into account the possibility of increased infections following specific surgical procedures. That is the ke ...
Medications Oct 31, 2011 | not rated yet | 0
Scientists reported Wednesday a super-strain of salmonella resistant to antibiotics, notably ciprofloxacin, which is commonly used to treat infections caused by the bacteria.
Diseases, Conditions, Syndromes Aug 03, 2011 | not rated yet | 0
A new study has identified the recent emergence of a multidrug-resistant strain of Salmonella that has a high level resistance to ciprofloxacin, a common treatment for severe Salmonella infections. The study, led by François-Xavier ...
Diseases, Conditions, Syndromes Aug 02, 2011 | not rated yet | 0